Testing Hydroxychloroquine’s Preventative Effects for Health Care Workers | Eastern North Carolina Now

Publisher's note: The author of this post is Jon Sanders for the John Locke Foundation.

    Background: In early April, as part of the JLF Research Division's ongoing series of research briefs recommending ways to address the coronavirus, I published a brief on the potential use of hydroxychloroquine to protect doctors, nurses, and first responders on the front lines of the fight against COVID-19.

    Here's a snippet:

  • What all this indicates is that what informed the passage of last week's emergency rule is no longer the best available information. There are more indications that these treatments are effective and less need to worry about a shortage. Several other states that initially passed limits or prohibitions on hydroxychloroquine have seen the same shifting landscape and subsequently changed their prohibitions.
  • Recommendation: Allow health care workers and first responders on the front lines to receive preventative prescriptions of hydroxychloroquine, chloroquine, azithromycin, etc.
  • Why: to protect them from the virus along with masks, gloves, and other PPE
  • All that being the case, DHHS should move to allow preventative or precautionary prescriptions of hydroxychloroquine, chloroquine, azithromycin, etc. for health care workers and first responders on the front lines in this all-out public health war. State health officials should also consider prescribing for their immediate families as well as patients awaiting test results (for as long as results take days to return). Physicians should, of course, give all due consideration of the risks of the drugs in determining whether it is suitable for each affected individual.
  • But along with masks, gloves, and other PPE, this could be a big boost in North Carolina's effort against the coronavirus.

    For that reason I found this news today intriguing, which was originally titled "Duke trial tests if hydroxychloriquine prevents COVID-19":

  • More than 800 health care workers have enrolled in a study based at Duke University to determine whether the antimalarial drug hydroxychloroquine can help ward off COVID-19, and organizers are looking for more volunteers.
  • Participants in the clinical trial are drawn from a pool of people who have enrolled in The Healthcare Worker Exposure Response and Outcomes (HERO) Registry. ...
  • So far, the only study drawing volunteers from the HERO Registry involves hydroxychloroquine or HCQ, which is used to treat malaria and autoimmune diseases such as rheumatoid arthritis and lupus.
  • The drug has received lots of attention from the public and the press after President Donald Trump endorsed it as a way to prevent coronavirus infection, then disclosed last month that he was taking it for that reason. The Food and Drug Administration has cautioned against using HCQ to treat COVID-19 unless administered in a hospital or as part of a clinical trial because of a risk of heart rhythm problems.

    As the article mentioned, Pres. Trump took a two-week course of hydroxychloroquine as a preventive treatment under the advice of a physician after two White House workers tested positive for COVID-19.

    It would be interesting to see whether Gov. Roy Cooper is taking or has taken hydroxychloroquine (or some other preventive regimen) as a precaution for participating in a mass gathering over 25 with no social distancing and no mask on properly.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published)
Enter Your Comment ( no code or urls allowed, text only please )




RNC Lite in Charlotte — ‘Disappointed but Hopeful’ John Locke Foundation Guest Editorial, Editorials, Op-Ed & Politics John Droz: An Anatomy of the Current Civil Discord


HbAD0

Latest Op-Ed & Politics

Be careful what you wish for, you may get it
America needs to wake up and get its priorities right
Former President Donald Trump suggested this week that if he becomes president again, he might allow Prince Harry to be deported.
It's a New Year, which means it's time to make resolutions — even for prominent evangelical leaders. The Babylon Bee asked the following well-known figures in the faith what they hope to accomplish in 2024:
Vice President Kamala Harris will visit a Minnesota Planned Parenthood clinic, reportedly the first time a president or vice president has visited an abortion facility.
An eight-mile stretch of the Blue Ridge Parkway near Asheville has been temporarily closed due to a string of “human and bear interactions,” the National Parks Service announced.
University of Wisconsin tried to punish conservatives for the fact that liberals regularly commit crimes to silence opposition
most voters think EU officials not doing a good job on illegal immigration
Come from behind by GOP candidate is a blueprint to 2024

HbAD1

Biden spending and energy policies to blame
Tuberculosis carried by illegal invaders has already infected Texas cattle
Sen. Ted Cruz (R-TX) said this week that the only campaign promise President Joe Biden has delivered on as president is the complete dismantling of the U.S. southern border.
Hamas is reeling after losing two of their most cherished leaders on the same day: military commander Saleh al-Arouri, and Harvard President Claudine Gay.
President Joe Biden’s brother told the Internal Revenue Service that Hunter Biden told him he was in business with a “protege of President Xi,” referring to the leader of China, according to notes by an IRS investigator that were divulged during a congressional interview of Jim Biden.
Gov. Roy Cooper seeks a temporary restraining order to block a law changing the composition of the State Board of Elections.
X owner Elon Musk mocked a news segment from ABC News this week that promoted President Joe Biden’s talking points about the Democrat-led Senate’s failed border bill, which critics and many experts have said would make the situation on the border worse.
That’s the question Marguerite Roza of Georgetown University’s Edunomics Lab sought to answer in a recent webinar on the topic.

HbAD2

 
Back to Top